Ruben Osnabrugge
InvestorPartner and Chief Medical Officer at 415 Capital
Greater Munich Metropolitan Area
About
Ruben Osnabrugge, MD PhD, is Partner and Chief Medical Officer at 415 Capital, where he combines clinical expertise with investment work in cardiovascular and medtech technologies. He trained in cardiothoracic surgery and holds a PhD in cardiovascular medicine, and focuses on evaluating and translating novel interventional therapies and medical devices into clinical practice. His investment responsibilities include clinical due diligence, strategic evaluation, and ongoing portfolio engagement.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthMedical Devices
Experience
- 415 CapitalPartnercurrent2023 — presentMunich, Bavaria, Germany
- Endovascular EngineeringMember Board of Directorscurrent2025 — presentMenlo Park, California, United States
- TRiCares GmbHBoard Observercurrent2024 — presentGreater Munich Metropolitan Area
- Cardiac Success Ltd.Member Board of Directorscurrent2023 — presentYokneam Ilit, North District, Israel
- Erasmus MCPostdoctoral Researcher Thoraxcentercurrent2015 — presentRotterdam, South Holland, Netherlands
- Erasmus MCMD Cardiothoracic surgery2016 — 2019
- Erasmus MCPhD fellow at the Dept. of Cardio-Thoracic Surgery2012 — 2015Rotterdam, South Holland, Netherlands
- Erasmus MCResearcher at Depts. of Cardio-Thoracic Surgery and Epidemiology2010 — 2012The Randstad, Netherlands
- Erasmus MCUniversity Council2010 — 2011
- Erasmus MCEducation Committee2008 — 2010
- EQT Life SciencesDirector / Investment Manager2021 — 2023Amsterdam, Munich, Boston
- XeltisBoard Observer2022 — 2023Eindhoven Area
- FundamentalVRBoard Observer2022 — 2023Greater London, England, United Kingdom
- LumavisionBoard Observer2022 — 2023Dublin, County Dublin, Ireland
- LSPAssociate2021 — 2022Amsterdam, Munich, Boston
- PhilipsGlobal Strategic Program Lead Value Based Care2019 — 2021The Randstad, Netherlands
- MedTech EuropeRepresentative2020 — 2021Brussels, Brussels Region, Belgium
- PCRFaculty2015 — 2021Greater Paris Metropolitan Region
- CTSNet / Cardiothoracic Surgeons NetworkEditor Journal and News Scan2013 — 2021Chicago, Illinois, United States
- European Association of Cardiothoracic SurgeryFaculty Member2013 — 2021Windsor, United Kingdom
- Franciscus Gasthuis & VlietlandGeneral Surgery Resident2018 — 2019Rotterdam, South Holland, Netherlands
- Eurointervention JournalAssociate Editor2013 — 2016The Randstad, Netherlands
- Saint Luke's Health SystemPHD Researcher2013 — 2014Kansas City Metropolitan Area
Skills & more
MedtechCardiovascular MedicineBoard GovernanceEpidemiology11Medicine6Surgery5Health Economics4Research2Healthcare14Clinical Research13Statistics2Public Health4
+12 more
EconomicsData AnalysisTeachingScienceTreeAgeLifesciencesClinical TrialsMedical EducationDutchEnglishArtsenPatiëntenzorgFrom Ruben's professional profile.
Colleagues at 415 Capital
Amra Hadziabdic
Executive Assistant at 415 Capital
Azin Parhizgar
Managing Director, US at 415 Capital
David Thompson
General Partner at 415 Capital
Eduardo Palma
Associate at 415 Capital
Frank Groenewegen
Chairman Emeritus at 415 Capital
Frederik Groenewegen
General Partner at 415 Capital
Hershel Groenewegen
Chief Happiness Officer at 415 Capital
Julia Hoffmeister
Investment Analyst at 415 Capital
Frequently asked questions
- Who is Ruben Osnabrugge?
- Ruben Osnabrugge, MD PhD, is Partner and Chief Medical Officer at 415 Capital, where he combines clinical expertise with investment work in cardiovascular and medtech technologies. He trained in cardiothoracic surgery and holds a PhD in cardiovascular medicine, and focuses on evaluating and translating novel interventional therapies and medical devices into clinical practice. His investment responsibilities include clinical due diligence, strategic evaluation, and ongoing portfolio engagement.
- Where does Ruben Osnabrugge work?
- Ruben Osnabrugge is Partner and Chief Medical Officer at 415 Capital.
- What does Ruben Osnabrugge invest in?
- Ruben Osnabrugge invests in Biotech, Digital Health, Medical Devices.
- Where did Ruben Osnabrugge go to school?
- Ruben Osnabrugge studied at Erasmus University Rotterdam (MD, Medicine); Netherlands Institute for Health Sciences (NIHES) (MSc, Health Sciences-Clinical Epidemiology); Harvard T.H. Chan School of Public Health.
Same school
Also attended Erasmus University Rotterdam181
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 175 more
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 887 more
Also attended Utrecht University91
René KuijtenInvestor at LSP (Life Sciences Partners)René R. KuijtenInvestor at LSP (Life Sciences Partners)Matthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at NoaberIrene KrijgsmanProgramma manager at NoaberMarlene van LooProgramma manager at Noaber
+ 85 more
Shared employers
Also worked at FundamentalVR4
Also worked at Lumavision5
Also worked at LSP14
Drew BurdonInvestor at LSP (Life Sciences Partners)Anna BellmuntSenior Associate at Asabys PartnersJoachim RothePartner at EQT Life SciencesFouad AzzamPartner at EQT Life SciencesJohn de KoningPartner at EQT Life SciencesAnne PortwichPartner at EQT Life Sciences
+ 8 more
Also worked at Philips104
Paul van OoikInvestment associate at NoaberLidwi van OsProgram & Office Support Officer at NoaberIdil KavakliExperts | Venture Partner at 212Daniel GrafGeneral Partner at redalpineNeelam DhawanTech Industry Trailblazer at SenseAI VenturesRobbert FlipsenEntrepreneur in Residence at Peak
+ 98 more





























.png)















